INARI MEDICAL, INC.

(NARI)
  Report
Delayed Nasdaq  -  04:00 2022-06-27 pm EDT
70.28 USD   -1.21%
06/24BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell Small Cap Comp Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 3000E Value Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inari Medical, Inc. Revises Revenue Guidance for the Full Year 2022

05/04/2022 | 04:01pm EDT

Inari Medical, Inc. revised revenue guidance for the full year 2022. For the full year 2022, the company revising its revenue guidance to a range of $360 million to $370 million, an increase of $10 million from its original guidance range of $350 million to $360 million.


© S&P Capital IQ 2022
All news about INARI MEDICAL, INC.
06/24BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell Small Cap Comp Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 3000E Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 2500 Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 3000 Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 2000 Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) dropped from Russell 2000 Growth-Defensive Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) dropped from Russell 2000 Defensive Index
CI
06/21Inari Medical's Shares Rise After Piper Sandler Initiates Coverage
MT
06/21Piper Sandler Starts Inari Medical at Overweight With $100 Price Target
MT
More news
Analyst Recommendations on INARI MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2022 365 M - -
Net income 2022 -38,5 M - -
Net cash 2022 316 M - -
P/E ratio 2022 -94,5x
Yield 2022 -
Capitalization 3 734 M 3 734 M -
EV / Sales 2022 9,37x
EV / Sales 2023 7,83x
Nbr of Employees 800
Free-Float 84,9%
Chart INARI MEDICAL, INC.
Duration : Period :
Inari Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INARI MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 70,28 $
Average target price 105,00 $
Spread / Average Target 49,4%
EPS Revisions
Managers and Directors
William H. Hoffman President, Chief Executive Officer & Director
Mitchell C. Hill Chief Financial Officer
Don B. Milder Chairman
Thomas Tu Chief Medical Officer
Tara Dunn VP-Clinical Affairs & Market Development
Sector and Competitors
1st jan.Capi. (M$)
INARI MEDICAL, INC.-22.06%3 779
NOVOCURE LIMITED0.69%7 907
MASIMO CORPORATION-52.66%7 693
SHOCKWAVE MEDICAL, INC.10.86%7 076
GETINGE AB-41.69%6 197
PENUMBRA, INC.-54.15%4 964